Ateliers d’harmonisation des pratiques de la SFGM-TC

Yakoub-Agha, 2014, [Fourth annual series of workshops of the SFGM-TC to harmonize practices in allogeneic stem cell transplantation], Pathol Biol (Paris), 62, 179, 10.1016/j.patbio.2014.05.001 Blaise, 2014, [Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 1)], Pathol Biol (Paris), 62, 180, 10.1016/j.patbio.2014.05.004 Nguyen, 2014, [Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)], Pathol Biol (Paris), 62, 185, 10.1016/j.patbio.2014.05.002 Farge, 2014, [Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC], Pathol Biol (Paris), 62, 204, 10.1016/j.patbio.2014.05.012 Calmels, 2014, [Conservation and destruction of autologous and allogeneic cryopreserved cellular products: recommendations from the SFGM-TC], Pathol Biol (Paris), 62, 221, 10.1016/j.patbio.2014.05.006 Bay, 2013, [Diagnosis and treatment of CMV and EBV reactivation as well as post-transplant lymphoproliferative disorders following allogeneic stem cell transplantation: an SFGM-TC report], Pathol Biol (Paris), 61, 152, 10.1016/j.patbio.2013.07.003 Deconinck, 2013, [How I manage respiratory syncytial virus, human herpesvirus 6 and adenovirus reactivation or infection after allogeneic stem cell transplantation: a report of the SFGM-TC], Pathol Biol (Paris), 61, 149, 10.1016/j.patbio.2013.07.012 Dulery, 2013, Pathol Biol (Paris), 61, 155, 10.1016/j.patbio.2013.07.011 Dulery, 2013, [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy], Pathol Biol (Paris), 61, 158 Loiseau, 2014, [Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC], Pathol Biol (Paris), 62, 226, 10.1016/j.patbio.2014.05.007 Choufi, 2014, [The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease], Pathol Biol (Paris), 62, 123, 10.1016/j.patbio.2014.02.013 Cornillon, 2013, [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis], Pathol Biol (Paris), 61, 171, 10.1016/j.patbio.2013.07.009 Cornillon, 2013, [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders], Pathol Biol (Paris), 61, 168, 10.1016/j.patbio.2013.07.010 Cornillon, 2013, [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on gonadal failure and fertility], Pathol Biol (Paris), 61, 164, 10.1016/j.patbio.2013.07.008 Vantyghem, 2014, Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation, Orphanet J Rare Dis, 9, 162, 10.1186/s13023-014-0162-0 de Berranger, 2014, [Managing late-effects after allogeneic stem cell transplantation in children: recommendations from the SFGM-TC], Pathol Biol (Paris), 62, 212, 10.1016/j.patbio.2014.05.009 Guillaume, 2014, [Prophylactic, preemptive and curative use of donor lymphocyte infusion in patients undergoing allogeneic stem cell transplantation: guidelines of the SFGM-TC], Pathol Biol (Paris), 62, 193, 10.1016/j.patbio.2014.05.011 Wallart, 2013, [A report of the SFGM-TC on the interactions between national transplant coordination and local coordinators in allogeneic stem cell transplantation activity], Pathol Biol (Paris), 61, 144, 10.1016/j.patbio.2013.07.006 Gauthier, 2015, [The role of pre-transplant debulking treatment in patients undergoing allogeneic stem cell transplantation for high-risk myelodysplastic syndrome], Bull Cancer, 102, 340, 10.1016/j.bulcan.2015.02.009 Dalle, 2014, [SFGM-TC recommendation on indications for allogeneic stem cell transplantation in children with congenital neutropenia], Pathol Biol (Paris), 62, 209, 10.1016/j.patbio.2014.05.008 Rohrlich, 2013, [Social connection: a report of the SFGM-TC on the maintaining social and family connections during hematopoietic stem cell transplantation], Pathol Biol (Paris), 61, 160, 10.1016/j.patbio.2013.07.002 Cornillon, 2014, [Transfer of skills: implementing post-transplant follow-up care status for transplant nurses: a report by the SFGM-TC], Pathol Biol (Paris), 62, 190, 10.1016/j.patbio.2014.05.003 Belaiche, 2014, [Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC], Pathol Biol (Paris), 62, 197, 10.1016/j.patbio.2014.05.010 Rubio, 2013, [Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report], Pathol Biol (Paris), 61, 139, 10.1016/j.patbio.2013.07.004 De Vos, 2014, Quality controls on cord blood unit contiguous segments: recommendation of the SFGM-TC, Pathol Biol (Paris), 62, 218, 10.1016/j.patbio.2014.05.005